Latest News about MRNA
Recent news which mentions MRNA
From Benzinga
Tesla, Take-Two and Exxon are among the exceptions to this big problem for stock prices
September 22, 2022
From MarketWatch
Health official says updated COVID-19 boosters likely to be available in weeks for elementary school-age children
September 22, 2022
From MarketWatch
Why Is Novavax (NVAX) Stock Falling Today?
September 22, 2022
From InvestorPlace
Cramer On COVID-19 Vaccine Stock: 'I Know It Can Go Lower, But I Think It's A Really Well-Run Company'
September 22, 2022
From Benzinga
From MarketWatch
3 Beaten-Down Stocks That Could Soar 51% to 70% From Their 52-Week Lows, According to Wall Street
September 21, 2022
From Motley Fool
Why Moderna Stock Topped the Market On Tuesday
September 20, 2022
From Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
September 20, 2022
From Benzinga
Could This Be Pfizer's Next Billion-Dollar Vaccine?
September 20, 2022
From Motley Fool
This Should Be a Wake-Up Call for Moderna Investors
September 20, 2022
Tickers
MRNA
From Motley Fool
Nikola, Super Micro Computer And Other Big Losers From Monday
September 20, 2022
From Benzinga
From Benzinga
Vaccine Stocks: Down but Not Out?
September 19, 2022
From Motley Fool
Why Moderna Stock Dropped Today
September 19, 2022
From Motley Fool
Why Are Vaccine Stocks MRNA, PFE, NVAX, BNTX Down Today?
September 19, 2022
From InvestorPlace
Health experts dismayed by President Biden’s view that the pandemic is over: ‘Hell no — not even close’
September 19, 2022
From MarketWatch
Why Virios Therapeutics Is Trading Lower By Over 71%, Here Are 55 Stocks Moving In Monday's Mid-Day Session
September 19, 2022
From Benzinga
Why BioNTech, Moderna And Novavax Shares Are Diving
September 19, 2022
From Benzinga
Amazon, Target And 3 Other Stocks Insiders Are Selling
September 19, 2022
From Benzinga
From Benzinga
Moderna Provides Vaccine For Preclinical Studies As WHO Tries Developing Its Own COVID-19 Shot: Report
September 19, 2022
From Benzinga
3 Beaten-Down Growth Stocks That Could Soar 60% to 188%, According to Wall Street
September 18, 2022
From Motley Fool
Europe may give COVID vaccines full marketing authorization to avoid annual review, and WHO backs Gilead’s Veklury for severe disease
September 16, 2022
From MarketWatch
Here's Why Wall Street Is Super Bullish on Moderna Stock
September 15, 2022
Tickers
MRNA
From Motley Fool
From Motley Fool
Nasdaq Closes Higher But CNN Fear & Greed Index Remains In 'Fear' Zone
September 15, 2022
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.